Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
CareDx, Inc
CDNA · SEC Filings
website
763
CareDx, Inc. is a global innovator specializing in the discovery, development, and commercialization...
Price
84.42
Market Cap
4.44 B
Float
50.8 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about CDNA
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
CareDx, Inc
CDNA · SEC Filings
50.8 M
Float
84.42
Price
4.44 B
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 28, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 4, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 6, 2025
News
TYPE
HEADLINE
FILED AT
8-K
CareDx Reports Q3 2026 Financial Results with 39% Revenue Growth and Raises Full-Year Guidance
Oct 29, 2026
8-K/A
Audited 2025 Financials Reveal $3.9 Million Net Loss and Substantial Going-Concern Doubt Ahead of Proposed $160 Million Acquisition
Sep 16, 2026
8-K
CareDx Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance
Jul 30, 2026
8-K
CareDx Completes Sale of Lab Products Business to Eurobio Scientific for $171.2 Million
Jul 7, 2026
8-K
CareDx, Inc. Announces Results of 2026 Annual Meeting of Stockholders
Jun 15, 2026
8-K
CareDx Reports Strong Q1 2026 Financial Results and Raises Full-Year Guidance
Apr 28, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B5
ATM | Offering amount: $200,000,000
Apr 14, 2022
424B5
1,923,077 Shares-
Jan 21, 2021
424B5
Common Stock-
Jan 19, 2021
424B5
3,906,250 Shares
Jun 11, 2020
424B5
Common Stock
Jun 9, 2020
424B5
2,000,000 Shares
Nov 14, 2018
Registrations
TYPE
HEADLINE
FILED AT
S-8
CareDx, Inc. Amends 2025 Inducement Plan to Increase Share Reserve
Jul 30, 2026
S-3ASR
April 2026 SHELF
Apr 28, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 4, 2025
S-8
Registration
Sep 13, 2024
S-8
Registration
Jun 21, 2024
POS AM
Common Stock EFFECTIVE
May 22, 2024
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jun 5, 2026
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 27, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 27, 2026
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 25, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 25, 2025
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 29, 2024
Ownerships
TYPE
HEADLINE
FILED AT
4
NEW
Kennedy Keith (Reporting)
Nov 9, 2026
4
NEW
Novack Jeffrey Adam (Reporting)
Nov 9, 2026
144
Form 144 - Report of proposed sale of securities
Nov 5, 2026
4
Cohen Fred E (Reporting)
Nov 4, 2026
4
Novack Jeffrey Adam (Reporting)
Nov 3, 2026
4
Novack Jeffrey Adam (Reporting)
Oct 5, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
May 24, 2024
CT ORDER
Form CT ORDER - Confidential treatment order
Dec 22, 2021
LETTER
Form UPLOAD - SEC-generated letter
Sep 1, 2020
CORRESP
Form CORRESP - Correspondence
Aug 26, 2020
LETTER
Form UPLOAD - SEC-generated letter
Aug 5, 2020
CT ORDER
Form CT ORDER - Confidential treatment order
Jul 16, 2019
